AMERICAN SHARED HOSPITAL SERVICES financials

AMS CIK 0000744825

Source: EDGAR filings · Built 2026-06-19T01:58:21Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -4.54M -7.77M -555.00K 6.85M -4.33M 6.09M
EBITDA 2.13M 3.37M 5.43M 7.21M 6.32M -2.49M
Working Capital -5.72M 15.85M 9.68M 13.55M 9.20M -1.53M
Net Debt 18.32M 11.11M -344.00K 1.68M 7.90M 10.47M
Gross Margin 18.03% 32.41% 43.82% 42.45% 38.16% 25.04%
Operating Margin -12.78% -9.90% 1.27% 12.31% 7.66% -53.05%
Net Margin -5.53% 7.71% 2.86% 6.73% 1.10% -39.57%
Return on Equity (ROE) -6.46% 8.68% 2.70% 6.14% 0.98% -36.62%
Return on Assets (ROA) -2.80% 3.63% 1.27% 3.02% 0.43% -16.17%
Current Ratio 0.76× 2.52× 1.90× 3.62× 2.56× 0.88×
Debt-to-Equity 0.91× 0.88× 0.59× 0.65× 0.81× 0.75×
Effective Tax Rate 15.31% -23.85% 61.93% 38.24% 28.41% 18.38%
Cash Conversion Ratio -1.99× 0.08× 9.37× 5.45× 32.30× -1.38×
Accruals Ratio -0.08× 0.03× -0.11× -0.13× -0.13× -0.38×
SBC % of Revenue 1.44% 1.32% 1.82% 2.02% 2.38% 1.68%
CapEx Coverage 0.41× 0.02× 0.91× 18.65× 0.59× 2.67×
Free Cash Flow Per Share $-0.69 $-1.16 $-0.09 $1.09 $-0.71 $0.99

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 28.08M 28.34M 21.32M 19.75M 17.63M 17.84M
Cost of Revenue 23.02M 19.16M 11.98M 11.36M 10.90M 13.37M
Gross Profit 5.06M 9.19M 9.34M 8.38M 6.73M 4.47M
Selling, General and Administrative Expense 7.08M 7.41M 7.02M 5.14M 4.53M 4.61M
Operating Income (Loss) -3.59M -2.81M 270.00K 2.43M 1.35M -9.46M
Income Tax Expense (Benefit) -493.00K -295.00K 431.00K 963.00K 269.00K -1.74M
Net Income (Loss) Attributable to Parent -1.55M 2.19M 610.00K 1.33M 194.00K -7.06M
Earnings Per Share, Basic $-0.23 $0.34 $0.10 $0.21 $0.03 $-1.14
Weighted Average Number of Shares Outstanding, Basic 6.62M 6.50M 6.36M 6.30M 6.04M 6.18M
Earnings Per Share, Diluted $-0.23 $0.33 $0.10 $0.21 $0.03 $-1.14
Weighted Average Number of Shares Outstanding, Diluted 6.62M 6.70M 6.39M 6.30M 6.06M 6.18M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 3.46M 11.03M 13.69M 12.34M 8.14M 3.96M
Assets, Current 17.72M 26.26M 20.46M 18.72M 15.09M 10.85M
Assets 55.48M 60.20M 48.16M 43.96M 45.43M 43.65M
Long-term Debt 17.40M 20.41M 13.29M 13.66M 15.70M 4.62M
Liabilities, Current 23.44M 10.40M 10.78M 5.17M 5.89M 12.38M
Long-term Debt, Excluding Current Maturities 0 17.34M 11.04M 12.21M 14.32M 3.44M
Liabilities 27.79M 30.17M 21.88M 18.33M 21.19M
Stockholders' Equity Attributable to Parent 24.03M 25.18M 22.62M 21.63M 19.89M 19.27M
Common Stock, Shares, Outstanding 6.58M 6.42M 6.30M 6.18M 6.05M 5.79M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 3.10M 167.00K 5.72M 7.24M 6.27M 9.74M
Payments to Acquire Property, Plant, and Equipment 7.63M 7.94M 6.27M 388.00K 1.67M 455.00K
Net Cash Provided by (Used in) Investing Activities -7.63M -7.11M -6.27M -388.00K -1.67M -2.39M
Net Cash Provided by (Used in) Financing Activities -3.03M 4.41M 1.91M -2.66M -655.00K -4.81M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AMS CIK 0000744825), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

SVAC

SPRING VALLEY ACQUISITION CORP. III

CGON

CG Oncology, Inc.

LFMD

LIFEMD, INC.